Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
    • For library administrators
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Journal of Cell Science
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Journal of Cell Science

  • Log in
Advanced search

RSS   Twitter  Facebook   YouTube  

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
    • For library administrators
Research Article
Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments
John E. Eriksson, Tao He, Amy V. Trejo-Skalli, Ann-Sofi Härmälä-Braskén, Jukka Hellman, Ying-Hao Chou, Robert D. Goldman
Journal of Cell Science 2004 117: 919-932; doi: 10.1242/jcs.00906
John E. Eriksson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tao He
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy V. Trejo-Skalli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann-Sofi Härmälä-Braskén
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jukka Hellman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying-Hao Chou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert D. Goldman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & tables
  • Info & metrics
  • PDF
Loading

Article Figures & Tables

Figures

  •   Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Inhibition of vimentin dephosphorylation in vivo induces hyperphosphorylation and disassembly of vimentin polymers. (A) 32P in vivo labeled BHK-21 cells were incubated without or with 20 nM of the protein phosphatase inhibitor cl-A for 10 and 20 minutes and with 50 nM cl-A for 30 minutes. The inhibition of constitutive vimentin phosphatase activities causes a dose and time-dependent elevation of vimentin phosphorylation, as shown in the autoradiography of the 32P in vivo labeled proteins separated by 10% SDS-PAGE. (B) The phosphorylation causes a disassembly of the vimentin IF filaments, which is reflected by their increase in both the low and high speed centrifugation supernatants, as measured by western blotting of the respective supernatant fractions. While the IF pool in the low speed supernatant is primarily composed of both large filament fragments and soluble subunits, the high speed supernatant contains only truly soluble subunits. The vimentin levels are elevated both in the low and high speed supernatants but desmin concentrations are only elevated in the low speed supernatants. This implies that desmin is not disassembled under these conditions into soluble subunits but merely fragmented. This is consistent with the phosphorylation of desmin, which is not elevated by inhibition of dephosphorylation. (C) The specific phosphorylation (32P labeling/protein units) of polymer-associated and depolymerized vimentin subunits was analyzed by double in vivo labeling with [32P]orthophosphate and [35S]methionine followed by phosphorimager analysis (32P + 35S is the signal collected from both isotopes on the gel; the 32P signal was obtained by exposure through four layers of aluminum foil). The results indicate that phosphate incorporation takes place both on polymer-associated vimentin and on the dissociated subunits, as shown by (D) quantification of the same specific levels of 32P per protein unit (32P/35S), with a certain preference for phosphate incorporation into the soluble subunits, as indicated by the ratios between the different protein pools, as compared to the filamentous pool (=1), shown above the bars.

  •   Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Phosphorylation-induced disassembly of vimentin IFs in vitro and in vivo results in disassembled subunits with the same molecular mass categories. (A) Bacterially expressed human vimentin IF polymers were phosphorylated in vitro by PKA and the resultant disassembly of depolymerized subunits was assayed by glutaraldehyde crosslinking (GA; concentration range: 0-0.06%) of the vimentin supernatant fractions after 30 minutes centrifugation at 200,000 g. (B) The in vitro disassembly of vimentin was compared to that in vivo, by incubating BHK-21 cells in the presence of 50 nM cl-A for 30 minutes. The cells were treated with 1% Triton X-100 and the particulate material was pelleted by centrifugation at 200,000 g for 30 minutes. The supernatants were then subjected to glutaraldehyde crosslinking (same concentration range as above) followed by immunoblottting. The results indicate that the phosphorylation-mediated release of vimentin subunits also occurs as tetramers in vivo.

  •   Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Phosphopeptide mapping of the major interphase-specific in vivo phosphorylation sites on vimentin. (A) The relatively low level of 32P-labeling of vimentin in interphase cells shown in Fig. 1, reflects constitutive phosphorylation on a few major sites, as indicated by the presence of a few more prominently labeled tryptic peptides (1, 4, 5, and 8) from vimentin isolated from untreated 32P in vivo labeled BHK-21 cells. (B) When dephosphorylation is inhibited with 20 nM cl-A for 20 minutes, all (except peptide 8) of these constitutively labeled phosphopeptides displayed significant increases in labeling and, in addition, many new peptides (2, 3, 6, 7) showed marked elevations in 32P labeling. These results indicate that there are some sites that maintain a certain level of constitutive phosphorylation and, in addition, some sites that are subjected to a high constitutive phosphate turnover. (C) The interphase-specific sites do not correspond to the mitosis-specific in vivo phosphorylation sites, as shown on a vimentin phosphopeptide map derived from in vivo labeled cells, blocked in metaphase by treatment with 2 μg/ml nocodazole for 3 hours. (D-H) The in vivo phosphopeptide maps were compared to those obtained by in vitro phosphorylation using a number of potential vimentin kinases. (D) PKA, (E) PKC, (F) CaMKII, (G) p37 K, and (H) cdc2 K, all resulted in characteristic phosphopeptide maps. Some of the major interphase-specific in vivo phosphopeptides showed a similar migration as the major phosphopeptides generated by PKA and PKC but not CaMK. The phosphopeptides generated by the mitotic kinases cdc2 K and p37 K did not correspond to any of the interphase-specific phosphopeptides but co-migrated with the major mitosis-specific phosphopeptides.

  •   Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Chromatographic separation of the major tryptic phosphopeptides from 32P in vivo labeled vimentin. Four 20 cm plates of semi-confluent BHK-21 cells were preincubated for 4 hours with 0.5 mCi/ml [32P]orthophosphate. In order to maximize the in vivo labeling, vimentin dephosphorylation was inhibited by addition of 50 nM cl-A to the cells. Vimentin was isolated by preparative SDS-PAGE as described in Materials and Methods and then subjected to tryptic cleavage. (A) The generated phosphopeptides were first isolated by reversed phase chromatography on a microbore C-18 column. The UV chromatogram (left panel) indicates the presence of a high number of tryptic peptides, among which seven 32P labeled fractions were isolated (right panel; fractions a-g). (B) Peaks a-g obtained on the C18 chromatography were then separated a second time on a reversed phase microbore C-8 column, yielding one single purified peptide from fractions a, b and d-g, and two peptides from fraction c. The inserts show the elution profile of the 32P label, which in all cases corresponded to a peak on the UV chromatogram. The isolated peptides were numbered according to their hydrophobicity on the C8 reversed phase HPLC. The obtained peaks were subjected to automatic sequencing and manual Edman degradation. Peptide masses were confirmed by mass-spectrometry (data not shown). The results are presented in Table 1.

  • Table 1.

    Information obtained on the phosphopeptides derived from in vivo labeled vimentin

    Peptide number Sequence obtained % Label released on cycle number Total number of cycles
    1 pSVSpSSSYR 1 (10%), 4 (70%), D(<10%) 6
    2 SVpSpSSSYR 3 (40%), 4 (50%), D (<10%) 6
    3 LRpSpSMPGVR 3 (50%), 4 (40%), D (<10%) 6
    4 DGQVINEpTpSQHHDDLE* No release, D (>90%) 6
    5 SLYSSpSPGGAYVTR 6 (90%), D (<10%) 6
    6 TYpSLGpSAL 3 (60%), 6 (20%), D (<10%) 6
    7 ETNLEpSLPLVDTHSK 6 (30%), D (>60%) 9
    8 ISLPLPNFSpSLNLR No release, D (>90%) 9
    • Phosphorylation sites (indicated in bold) on the basis of the results of the manual Edman degradation.

      Peptides were numbered on the basis of increasing hydrophobicity on C8 HPLC. The sequence obtained for each isolated phosphopeptide is indicated together with the data obtained from the manual Edman degradation. The cycle in which release of label was observed during Edman degradation is shown. D refers to the crosslinked material remaining on the Sequelon membrane discs after completion of the Edman degradation cycles.

    • ↵* The phosphorylation sites of peptide 4 to Thr-457 and Ser-458 were assigned based on the results of Chou et al. (Chou et al., 1996).

  • Table 2.

    Suggested sequences for the phosphopeptides on the tryptic peptide maps

    Peptide number on Fig. 3 Peptide number on Fig. 4 and Table 1 Manual Edman degradation: % label released on cycle number Total number of cycles Suggested sequence
    1 6 3 (60%), 6 (30%), D (< 10%) 6 TYpSLGpSAL
    2 3 3 (70%), 4 (20%), D (<10%) 6 LRpSpSMPGVR
    3 3 3 (50%), 4 (30%), D (<10%) 6 LRpSpSMPGVR
    4 7 6 (30%), D (>60%) 14 ETNLEpSLPLVDTHSK
    5 1,2 1 (30%), 3 (30%), 5 (<10%), 6 (10%), D (<10%) 6 pSVpSSpSpSYR
    6 1,2 5 (60%), 6 (30%), D (<10%) 6 SVSSpSpSYR
    7 1,2 6 (70%), D (<10%) 6 SVSSSpSYR
    8 5 6 (90%), D (<10%) 6 SLYSSpSPGGAYVTR
    9 4 No release, D(>90%) 6 DGQVINEpTpSQHHDDLE
    • Manual Edman degradation was carried out on the phosphopeptides eluted from the TLC plates used for peptide mapping; D, disc. The results indicate the cycle when release of the label was observed. The suggested sequence for the peptide is partly based on the available sequence information and partly based on the knowledge of migration characteristics of previously isolated known phosphopeptides. The phosphorylation sites of peptide 4 to Thr-457 and Ser-458 were assigned based on Chou et al. (Chou et al., 1996).

  •   Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Identified in vivo phosphorylation sites on vimentin. (A) A summary of all results obtained by phosphopeptide mapping, sequencing and manual Edman degradation. P, identified phosphorylation sites; *, sites that have not been previously described as in vivo phosphorylation sites. (B) The schematic figure shows the relative location of the phosphorylation sites in the N and C termini of vimentin.

  •   Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Mutation of the two major PKA sites results in a reduction of vimentin phosphorylation and alters the phosphate distribution on vimentin phosphopeptides. When two-dimensional tryptic phosphopeptide mapping of PKA-phosphorylated (A) wild-type and (B) S38:A/S72:A vimentin was performed, peptide 1 showed negligible phosphorylation in the mutant vimentin, whereas peptide 2 showed reduced phosphorylation. Each map was loaded with peptides generated from 5 μg of 32P-labeled vimentin. The direction of electrophoresis (+,-) and ascending chromatography (arrow) are indicated. (C) An overall reduction in 32P incorporation as a result of the phosphate-site mutations could be seen when 7.5 μg of wild-type (lane 1) and S38:A/S72:A (lane 2) vimentin, respectively, were phosphorylated in vitro by PKA and subjected to one-dimensional SDS-PAGE followed by autoradiography.

  •   Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Presence of phosphate groups on Ser-38 and Ser-72 affect filament forming ability following microinjection into BHK-21 fibroblasts. (A) Wild-type (a-c), PKA-phosphorylated wild-type supernatant fraction (d-f), and S38:A/S72:A (g-i) myc-tagged vimentin were microinjected at a concentration of 1 mg/ml into BHK-21 fibroblasts. At 10 minutes (a, d, g), 30 minutes (b, e, h) and 3 hours (c, f, i) post-injection, cells were fixed with methanol and indirect immunofluorescence was performed using a monoclonal antibody directed against the myc-tag to trace the microinjected protein. Filament formation by the injected protein was assessed, and confocal micrographs were obtained, demonstrating the degree of filament formation observed for the majority of cells at a given time point. (B) Co-localization of the injected protein with the endogenous BHK-21 IF network was determined at 3 hours post-injection by double-label immunofluorescence using a polyclonal antibody specific for the endogenous vimentin (a, b, c). The images show the behavior of the S38:A/S72:A mutant pelletable protein but similar results were obtained with all three injected proteins.

Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

 Download PDF

Email

Thank you for your interest in spreading the word on Journal of Cell Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments
(Your Name) has sent you a message from Journal of Cell Science
(Your Name) thought you would like to see the Journal of Cell Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments
John E. Eriksson, Tao He, Amy V. Trejo-Skalli, Ann-Sofi Härmälä-Braskén, Jukka Hellman, Ying-Hao Chou, Robert D. Goldman
Journal of Cell Science 2004 117: 919-932; doi: 10.1242/jcs.00906
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments
John E. Eriksson, Tao He, Amy V. Trejo-Skalli, Ann-Sofi Härmälä-Braskén, Jukka Hellman, Ying-Hao Chou, Robert D. Goldman
Journal of Cell Science 2004 117: 919-932; doi: 10.1242/jcs.00906

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • Summary
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & tables
  • Info & metrics
  • PDF

Related articles

Cited by...

More in this TOC section

  • An SNX10-dependent mechanism down-regulates fusion between mature osteoclasts
  • Combined heterogeneity in cell size and deformability promotes cancer invasiveness
  • Non-canonical ago loading of EV-derived exogenous single stranded miRNA in recipient cells
Show more RESEARCH ARTICLE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Experimental Biology

Disease Models & Mechanisms

Biology Open

Advertisement

Follow us on Instagram

Cell science is bursting with beautiful images and over on Instagram, we’re showing them off! Find both JCS and FocalPlane on Instagram for stories and techniques across cell biology.


An interview with Derek Walsh

Professor Derek Walsh is the guest editor of our new special issue Cell Biology of Host-Pathogen Interactions. In an interview, Derek tells us about his work in the field of DNA viruses, the impact of the pandemic on virology and what his role as Guest Editor taught him.


How to improve your scientific writing

"If you are a scientist and you want to succeed, you must become a writer."

How do scientists become master storytellers? We called on our journal Editors, proofreaders and contributors to our community sites for their advice on how to improve your scientific writing.


Meet the preLighters: Jennifer Ann Black

Following the theme of our latest special issue, postdoc Jennifer Ann Black studies replication stress and genome plasticity in Leishmania in Professor Luiz Tosi’s lab in Sao Paolo. We caught up with Jenn (virtually) to hear about her relocation to Brazil mid-pandemic, her research on parasites and what she enjoys about ‘preLighting’.

In our special issue, Chandrakar et al. and Rosazza et al. present their latest work on Leishmania.


Mole – The Corona Files

“There are millions of people around the world who continue to believe that the Terrible Pandemic is a hoax.”

Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.


JCS and COVID-19

For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.

If you have any questions or concerns, please do not hestiate to contact the Editorial Office.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Special issues
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About Journal of Cell Science
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Fast-track manuscripts
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • JCS Prize
  • Manuscript transfer network
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contacts

  • Contact JCS
  • Subscriptions
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992